Press Releases
January 18, 2022
NexImmune to Participate in The Leukemia & Lymphoma Society Therapy Acceleration Program® (LLS TAP) Panel on “Expanding the Possible with Next-Generation Cell Therapies”
January 5, 2022
NexImmune Announces Formation of Autoimmune and Infectious Diseases Scientific Advisory Board
December 12, 2021
NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results in Patients with Multiple Myeloma
November 12, 2021
NexImmune Reports Third Quarter 2021 Financial Results and Provides Business Updates
November 8, 2021
NexImmune to Announce Third Quarter 2021 Financial Results and Provide Corporate Update on November 12, 2021
November 3, 2021
NexImmune to Present at The Society for Immunotherapy of Cancer 36th Anniversary Annual Meeting
September 27, 2021
NexImmune to Present at the 2021 Cantor Virtual Global Healthcare Conference
September 10, 2021
NexImmune to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
August 9, 2021
NexImmune Reports Second Quarter 2021 Financial Results and Provides Business Updates
August 9, 2021
NexImmune to Explore the Use of AIM™ Direct Injection Technology in Type 1 Diabetes
Displaying 31 - 40 of 73